Catalyst Wire Dossier Catalyst Wire Dossier

Neucardin

neucardin · Zensun Sci. & Tech. Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Neucardin, covering 2024-07-25 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure [Phase 3]

See pricing